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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S236genotype (p < 0.05). In radiological features, no changes was observed
in vitamin D group whereas in placebo group decreased Medial-JSW
and increased Osteophyte was observed in Tt and tt genotype in com-
parion to TT genotype of TaqI polymorphism. These changes were of
borderline signiﬁcance. No similar effect was observed for ApaI
polymorphism.
Conclusions: VDR gene polymorphism (TaqI) inﬂuences the clinico-
radiological response to vitamin D supplementation in Osteoarthritis
knee with insufﬁcient 25-OHD levels. If these results are conﬁrmed by
the larger studies, this would justify tailoring vitamin D supplementa-
tion using VDR genotyping in vitamin D insufﬁcient KOA patients.
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Purpose: Osteoarthritis represents an increasing threat worldwide,
affects people of all ages, inducing premature disability and economic
impairment. Bioinformatics, computational and systems biology are
used for deﬁning molecular proﬁle of diseases by integrating available
information. This approach requires knowledge about details as well as
overview about predictable interconnections. Bioinformatics is pro-
posed as a tool in organizing existent knowledge aiming introduction of
the discovery science principles in handling clinical and experimental
data. Computational biology is used to detect possible correlations and
links in molecular pathways and further pointed as one useful method
to design focused systematic research.
Methods: Genes and proteins involved in the process speciﬁc to Homo
sapiens have been extracted using data available in Gene Cards, Uniprot,
pubmed cited literature and gene ontology (GO) databases. Interactions
network analysis was build using Gene Regulatory Network (GRN) and
Gene Set Enrichment Analysis (GSEA) considering the following factors;
down and up regulation, co expression, predicted protein interaction,
Transcription Factor (TF) regulation. ChIP-seq data sets were aligned
usin to build version version hg19 of the human genome. Enhancers
were deﬁned as regions of ChIP-seq enrichment for H3K27ac in human
cells.
Results: Several sets of genes previously associated with chondrocyte
metabolism and inﬂamation were identiﬁed. Gene expression not
previously associated with OA have been identiﬁed. OA-associated SNPs
appear in super-enhancers of chondroprogenitor cells.
Conclusion: systems biology approach in disease characterization has
the potential in deﬁning the pathological mechanisms, in offering bio-
marker and therapeutical targets. Our approach is acontribution in this
respect towards a deﬁnition of osteoarthritis.
422
IMPROVED PREDICTION OF KNEE OSTEOARTHRITIS PROGRESSION
BY GENETIC POLYMORPHISMS. ARTHROTEST STUDY RESULTS
F.J. Blanco y, I. M€oller z, Arthrotest Study Group, N. Bartolome x,
M. Artieda x, D. Tejedor x, A. Martínez x, E. Montell k, H. Martínez k,
M. Herrero k, J. Verges k. y INIBIC-Hosp. Univ.rio A Coru~na, A Coru~na,
Spain; z Inst. Poal de Reumatología, Barcelona, Spain; x Progenika
Biopharma, S.A., Bilbao, Spain; kBioiberica S.A., Barcelona, Spain
Purpose: Single Nucleotide Polymorphisms (SNPs) are inherited
genetic variations that can predispose or protect individuals against
clinical events. Osteoarthritis (OA) has a multifactorial etiology with a
strong genetic component. Genetic factors inﬂuence not only knee OA
onset, but also disease progression. The aim of this study was to develop
a genetic prognostic tool to predict radiologic progression towards
severe disease in primary knee OA (KOA) patients.
Methods: Cross-sectional, retrospective, multicentric, association study
with Spanish KOA patients. 595 patients from 31 sites were selected.
Inclusion criteria: Caucasian patients aged 40 years at the time of
diagnosis of primary KOA, for whom two anteroposterior X-rays were
available, one corresponding to the time of OA diagnosis with Kellgren–
Lawrence grade 2 or 3 and the other to the end of the follow-up period.Patients who progressed to KL score 4 or were referred for total knee
replacement in  8 years since the diagnosis were classiﬁed as pro-
gressors to severe disease. A unique expert viewer measured the radi-
ologic progression from all X-rays. A candidate gene study analyzing
774 SNPs was conducted. SNP genotyping was performed with Illumina
Golden gate technology or KASPar chemistry. Clinical variables of the
initial stages of the disease (gender, BMI, age at diagnosis, OA in the
contralateral knee and OA in other joints) were registered as potential
predictors. Univariate analysis was done to identify associations
between the baseline clinical variables or SNPs and KOA progression.
SNPs and clinical variables with an association of p < 0.05 were inclu-
ded on the multivariate analysis using forward logistic regression.
Results: 282 patients fulﬁlled DNA and X-ray quality control criteria
(220 in the exploratory cohort and 62 in the validation cohort). The
univariate association analysis showed that one of the clinical variables
and 23 SNPs were signiﬁcantly associated to KOA severe progression in
the exploratory cohort (p < 0.05). The predictive accuracy of the clinical
variable was limited, as indicated by the area under the ROC curve (AUC
¼ 0.66). When genetic variables were added to the clinical model (full
model) the prediction of KOA progression was improved and the AUC
increased to 0.82. Combining only genetic variables, a predictive model
with a good accuracy (AUC ¼ 0.78) was also obtained. The predictive
ability for KOA progression of the full model was conﬁrmed on the
validation cohort (two-sample Z-test p ¼ 0.190).
Conclusions: Genetic polymorphisms predict radiologic progression
more accurately than clinical variables. An accurate prognostic tool to
predict primary KOA progression has been developed, based on genetic
and clinical information from OA patients. This model could help
clinicians optimize patients’ preventive and therapeutic care, according
to their OA progression rate, and personalize disease management.
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FUNCTIONAL ANALYSIS OF THE OSTEOARTHRITIS SUSCEPTIBILITY
LOCUS MARKED BY THE POLYMORPHISM rs10492367
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Purpose: The arcOGEN genome-wide association study, published in
2012, reported that the rs10492367 G to T single nucleotide poly-
morphism (SNP) marks a region on chromosome 12p that is associated
with hip osteoarthritis (OA) in Europeans, with an odds ratio (OR) of
1.14 and a p-value of 1.48  108. rs10492367 is an intergenic SNP
located 59 kb downstream of kelch domain-containing protein 5
(KLHDC5) and 96 kb downstream of parathyroid hormone-like hor-
mone (PTHLH). While there is sparse published data for KLHDC5,
PTHLH has been widely studied, with its protein having a crucial role in
endochondral ossiﬁcation. As rs10492367 is not in high linkage dis-
equilibrium (LD) with any common non-synonymous transcript poly-
morphisms, it is unlikely that the OA association is due to a change in
the coding sequence of either of these two nearby genes. Instead,
rs10492367 could function as a cis-acting polymorphism, inﬂuencing
PTHLH or KLHDC5 gene transcription, resulting in allelic expression
imbalance (AEI). Furthermore, as rs10492367 resides in a region pre-
dicted to have enhancer activity based on the ENCODE dataset, identi-
ﬁcation of functional variants within this region that affect such activity
will prove vital in dissecting the OA signal. Thus, the aims of this study
are to assess whether rs10492367 marks AEI in either PTHLH or
KLHDC5, and to determine if any intergenic SNPs in high LD (0.8) with
rs10492367 are functionally active in regulating enhancer activity of
this OA associated region.
Methods: Cartilage was obtained from the hip or knee of OA patients
who had undergone elective total joint replacement, and from non-OA
patients who had undergone total joint replacement as a result of a
neck-of-femur fracture (NOF). Using quantitative real-time polymerase
chain reaction (qPCR), overall expression of PTHLH and KLHDC5 was
measured in cDNA synthesised from cartilage RNA and stratiﬁed by
rs10492367 genotype. Allelic expression imbalance analysis was per-
formed using pyrosequencing. Since rs10492367 is intergenic, the
transcript SNPs rs6253 in PTHLH and rs9029 in KLHDC5 were used as
markers to measure allelic imbalance in 29 and 21 heterozygous OA
patients, respectively. The data was stratiﬁed by rs10492367 genotype
to evaluate whether any allelic differences corresponded to the pres-
ence of either of the association SNP alleles. Eight SNPs were in an LD of
0.8 with the association SNP; thus, 18 pGL3 promoter vector con-
structs were generated, each of which contained one of the alleles from
